Centrosomes are major microtubule-organizing centers composed of centrioles surrounded by an extensive proteinacious layer called the pericentriolar material (PCM). In C. elegans embryos, the mitotic PCM expands by Polo-kinase (PLK-1) phosphorylation-accelerated assembly of SPD-5 molecules into supramolecular scaffolds. However, how PLK-1 phosphorylation regulates SPD-5 assembly is not known. We found that a mutant version of SPD-5 that is insensitive to PLK-1 phosphorylation (SPD-5 4A ) could localize to PCM but was unable to rescue the reduction in PCM size and density when wild-type SPD-5 levels were decreased.
INTRODUCTION
Centrosomes are the main microtubule-organizing centers of animal cells, consisting of a pair of centrioles that organize a dynamic protein mass called pericentriolar material (PCM). The PCM consists of a structured, small interphase layer [1, 2] around which, amorphous mitotic PCM assembles to achieve maximal microtubule nucleation to facilitate mitotic spindle assembly. Despite the importance of PCM in microtubule organization, the mechanisms behind mitotic PCM formation remain elusive. In C.elegans, large-scale RNAi screens and genetics have revealed a limited number of components required for PCM assembly: SPD-2 [3, 4] , the polo-like kinase PLK-1 [5] and SPD-5 [6] . It was also shown that similar proteins are involved in PCM assembly in other species, suggesting that a universal assembly mechanism may exist. For instance, PCM assembly in vertebrates and Drosophila requires the assembly of large proteins such as Pericentrin/D-PLP and Cdk5RAP2/Centrosomin, which resemble in that they contain numerous interspersed coiled-coil domains [6] [7] [8] [9] [10] [11] . The assembly of these proteins is facilitated by SPD-2/Cep192 and the phosphorylation activity of the conserved Polo-like-kinase Plk1/PLK-1 [3] [4] [5] [12] [13] [14] [15] . However, how these molecular interactions lead to PCM assembly and determine final PCM size and density remain outstanding questions.
We previously hypothesized that PCM is nucleated at centrioles and then rapidly expands via autocatalytic incorporation of cytosolic PCM components [16] . In our model, unassembled PCM proteins exist in a soluble form that can transition into an assembly-competent state within the PCM and then become stably incorporated. Once incorporated, PCM proteins will recruit additional PCM components, which is an autocatalytic event. Consequentially, in our model the kinetics of PCM assembly depend on the rate by which PCM material, after being recruited to the centrosome, converts from the soluble to the assemblycompetent form. The existence of such a conversion is supported by the observations that C. elegans PCM proteins are indeed monomeric in cytoplasm prior to assembly, whereas they interact at the centrosome [17] .
We recently reported that purified SPD-5 can form supramolecular PCM-like assemblies in vitro, the formation of which is accelerated by PLK-1 phosphorylation of SPD-5 [12] .
Mass spectrometry revealed PLK-1 phosphorylation sites on SPD-5 that, when mutated, prevented PCM assembly in vivo. These results indicate that PCM formation in C. elegans is driven by Polo
Kinase-mediated oligomerization of SPD-5 around centrioles. We also found that only SPD-5 assemblies, and not SPD-5 monomers, recruited other PCM proteins, including PLK-1, leading us to propose that this emergent scaffolding property of SPD-5 could be the basis for autocatalytic PCM expansion in vivo [12, 17] . Additionally, our vitro experiments revealed that the stability and scaffolding capacity of SPD-5 assemblies were independent of PLK-1 phosphorylation, suggesting that Polo Kinase activity may only regulate the speed of SPD-5 assembly. However, we did not test whether Polo Kinase has additional roles in PCM maintenance or function in vivo. Nor did we test if unphosphorylated SPD-5 can be recruited to existing PCM and then be converted to an assembly-competent state as predicted by our previous model [16] .
In this study, we combined in vivo analysis, in vitro reconstitution, and modeling to investigate how Polo Kinase regulates SPD-5 assembly to form PCM in C.
elegans. Our results indicate that Polo Kinase phosphorylation affects the rate of SPD-5 assembly without dramatically affecting SPD-5 recruitment to existing PCM, PCM stability, or PCM function. Additionally, we conclude that a phosphosite binding mechanism cannot explain PCM assembly. Rather, we propose that SPD-5 naturally isomerizes between assembly-incompetent and assemblycompetent states, and that Polo Kinase phosphorylation biases SPD-5 toward the latter state. Furthermore, our results suggest that the conversion rate of SPD-5 into an assembly competent state is the key determinant of final PCM size and density in vivo.
RESULTS AND DISCUSSION

A SPD-5 phospho-mutant binds to PCM in C. elegans embryos
We first set out to determine if PLK-1 phosphorylation of SPD-5 is required only for PCM expansion or also for SPD-5 binding to PCM. For this purpose we used spinning disk confocal microscopy to observe PCM assembly in C. elegans embryos expressing GFP-tagged versions of SPD-5 (SPD-5 WT and SPD-5 4A ) as their sole source of SPD-5. SPD-5 4A is mutated in the critical sites for PLK-1 mediated centrosome assembly in vivo ( Figure 1A ; [12] ). As previously shown, GFP::SPD-5 4A localized to pre-mitotic centrosomes, but, in contrast to GFP::SPD-5 WT , failed to expand the PCM ( Figure 1B ; [12] Figure   1C ). By comparing centrosome sizes determined from GFP signal we found that PCM assembled in the presence of endogenous SPD-5 and GFP::SPD-5 4A was ~58% smaller in volume (3.8 ± 0.4 µm 3 , mean ± SEM) at nuclear envelope breakdown (NEBD) than PCM assembled with endogenous SPD-5 and wild-type GFP::SPD-5 (8.0 ± 1.0 µm 3 , mean ± SEM) ( Figure 1D ). As reported previously, GFP::SPD-5 WT and GFP::SPD-5 4A , as well as endogenous SPD-5 levels, are similar in these worms (~30% transgene, ~70% endogenous), suggesting that this difference does not result from altered SPD-5 concentrations ( Figure S1A , [12] ). We conclude that SPD-5 4A binds to PCM and that its expression reduces PCM expansion.
In addition to being smaller, centrosomes assembled in the presence of the SPD-5 4A mutant were also less dense. Based on the assumption that SPD-5 forms the underlying PCM scaffold [6, 12] , we used GFP::SPD-5 fluorescence at the PCM to approximate PCM density from the mean pixel intensity of maximum intensity WT levels to about 63% compared to the control condition, while fully removing the endogenous copy in both cases ( Figure 2H ). Reduction of GFP::SPD-5 WT reduced PCM volume by ~40% (3.9 ± 1.2 µm 3 , p < 0.001) and PCM density by ~34% , (p < 0.001) ( Figure 2I and 2J). These changes in centrosome size and density were similar to changes observed when GFP::SPD-5 4A was ectopically expressed (see Figure 1D and 2A act as a dominant negative mutant. We directly tested this hypothesis using an in vitro assay for PCM assembly developed in our lab [12] .
Similar to our observations in vivo, we found that purified SPD-5 4A ::GFP localized to PCM-like networks formed with SPD-5 WT ::TagRFP in vitro ( Figure 3A ). Figure 3B ). In contrast, total network mass in the sample containing SPD-4A was only slightly higher than the control sample, and the difference was not statistically significant (p = 0.86) ( Figure 3B [21] ). We permeabilized embryos using partial knockdown of perm-1 via RNAi [22] , then identified pre-mitotic embryos where 
A PLK-1-dependent SPD-5 conversion model can explain in vivo PCM assembly
Our data, combined with previous studies, allow us to propose a simple mechanism for PLK-1-dependent PCM assembly in C.elegans. Prior to incorporation into the PCM, SPD-5 is mostly monomeric and does not interact with SPD-2 or PLK-1 [17] . We term this the inactive form of SPD-5, which cannot contribute to PCM assembly itself but can localize to centrioles and segregate into existing PCM ( Figure 4E ). Since GFP::SPD-5 4A alone is not capable of expanding PCM in vivo ( Figure 1B and D), we assume that SPD-5 4A as well as unphosphorylated SPD-5 WT exist primarily in the inactive form. Secondly, we define an active, assembly-competent form, which can self-assemble into supramolecular structures and contribute to PCM growth ( Figure 4E ). Because our in vitro data show that purified SPD-5 can spontaneously self-assemble and that PLK-1 phosphorylation accelerates this assembly process [12] , we propose that SPD-5 can transition into the assembly-competent state spontaneously and that this transition is much more likely if SPD-5 is phosphorylated by PLK-1.
Thus, we assume that Polo kinase-phosphorylated SPD-5 exists predominately in the assembly-competent state.
Based on this idea we constructed a mathematical model (see SI) in which the inactive form of SPD-5 can be converted locally at the centrosome into the assembly-competent form through an active process such as Polo kinase phosphorylation [16] . We used this model to fit the accumulation rate of total is to bias SPD-5 isomerization towards the assembly-competent state. Besides PLK-1 phosphorylation, PCM assembly requires SPD-2, a protein known to control centrosome growth rate and thus size in vivo [5, 23] . We have shown previously that SPD-2 accelerates SPD-5 assembly in the presence and absence of PLK-1 in vitro, demonstrating that multiple mechanisms regulate SPD-5 selfassembly [12] . Whether SPD-2 also enhances SPD-5 self-assembly by affecting its isomerization or by some other process remains to be investigated. We conclude that SPD-5 has the intrinsic capability to assemble functional PCM and that PLK-1 phosphorylation and SPD-2 simply accelerate the rate of assembly.
An unexpected observation from our experiments was that PCM density increased over time from fertilization until mitosis in wild-type embryos.
However, when we reduced the speed of PCM assembly by reducing the available pool of phosphorylation-receptive SPD-5, PCM density did not change over time. We do not understand the molecular basis of this phenomenon. One possibility is that this is caused by a buildup of elastic stress as the centrosome grows. If the growth rate is faster than the stress relaxation rate, centrosome density will increase. However, if the growth rate is slowed down, for instance, by reducing the concentration of wild-type SPD-5, then the stress could relax and centrosome density would remain constant. This supports the idea that the PCM is not solid, but rather a viscous, gel-like material, which forms by phase transition of soluble molecules into PCM. This notion is further supported by the observation that GFP::SPD-5 4A localized to PCM without interfering with the expansion of the scaffold.
In D. Melanogaster, PCM assembly is driven by Polo kinase-regulated multimerization of the scaffolding protein Centrosomin [13] , suggesting that
Centrosomin is the functional homolog of SPD-5. Similar to SPD-5, Centrosomin must be phosphorylated at multiple residues to achieve its full scaffolding potential [13] . In vertebrate cells, Polo kinase and the Centrosomin homolog CDK5Rap2 are also required for mitotic PCM assembly [24, 25] . Thus, a common mechanism for PCM assembly is emerging that centers on Polo kinase-mediated phosphorylation of large coiled-coil proteins. It will be of interest to determine the similarities in self-assembly properties and regulation of SPD-5, Centrosomin, and CDK5Rap2.
MATERIALS AND METHODS
Worm strains
C. elegans worm strains were maintained following standard protocols [26] . For this study we used previously described worm strains OD847 
RNAi treatments
RNAi against endogenous spd-5 was carried out as previously described [27] .
Briefly, the following primers were used to amplify nucleotides 501 -975 of endogenous spd-5 from cDNA and cloned into Gateway® pDonor™221 vector via BP reaction to create spd-5-pENTR™ vector: 
Antibodies and Stainings
Stainings were done following standard procedure described before [6] . The polyclonal mouse αPLK-1 antibody was generated in house by injecting 1 mg of purified full length PLK-1 into mice, purified from serum, and used in a dilution of 1:300. Endogenous SPD-5 and SPD-2 were detected using the previously described polyclonal rabbit αSPD-2 antibody (anit-spd-2_NT_Acid, dil. Centrosome volume was then calculated using the centrosome radius approximated from centrosome area measurements. Total SPD-5 amounts were approximated from centrosome volumes and densities. We multiplied the volumes with concentration corrected intensity values, assuming that the recorded intensities stemmed from the 30% of the total SPD-5 pool labeled with GFP.
In vitro SPD-5 scaffold assembly
Proteins were purified and assembled into scaffolds in vitro as previously described [12] . For a detailed protocol please refer to [29] . In brief, all reactions were carried out in network buffer (25 mM HEPES, pH 7.4, 135 mM KCl, 125 mM NaCl, 0.2 mM ATP, 10 mM MgCl 2 ,1 mM DTT, 0.02% CHAPS, 0.2% glycerol, 0.025 mg/ml Ovalbumin) plus pre-blocked 0.2 µm red fluorescent polystyrene beads (Invitrogen) to aid in finding the focal plane. All proteins and reagents were stored on ice prior to being mixed, aliquoted into multiple tubes, then incubated at 23°C. 2 µl of a particular reaction was spotted onto a non-frosted cover slide, then covered with 18 x 18 mm pre-cleaned hydrophobic cover slips.
Cover slips were cleaned and made hydrophobic using the following steps. First, cover slips were placed in a Teflon holder and submerged in a 1:20 dilution of Mucasol detergent (Sigma) for 10 min with sonication. Second, the cover slips were transferred to 100% Ethanol and incubated for 10 min with sonication.
Third, the cover slips were incubated in a 50 % solution of Rain-X (diluted in ethanol) for >30 min, then washed in ethanol, then twice in water. Finally, the cover slips were dried using N 2 gas and stored in a desiccation chamber.
PLK-1 inhibition in embryos with permeabilized eggshells
PLK-1 inhibition was performed as previously described [12] . Briefly, L4 worms were seeded onto feeding plates containing bacteria expressing perm-1 dsRNA and incubated at 20°C for 14-20 hours [22] . Worms containing permeabilized embryos were dissected in an imaging chamber (Microwells) containing osmotic support medium (stock solution: 50 ml ESF 921 Insect Cell Culture Medium (Expression Systems) + 5ml Fetal Bovine Serum + 0.77g Sucrose, filter sterilized; this stock solution was then diluted 60/40 in M9 buffer). To inhibit PLK-1 AS prior to mitotic entry, the buffer was exchanged for buffer containing 10 µM 1-
NM-PP1 (Cayman chemical company, Cat#13330
). At the end of each experiment, FM4-64 (Molecular Probes, # T13320) was added to the well to confirm that the imaged embryo was permeable. Imaging was performed as described above, except that 10s intervals and 8% laser power (4.5 mW) were used.
Analysis of diffusion using fluorescence correlation spectroscopy (FCS)
FCS measurements and diffusion analysis were carried out as described previously [17] . Briefly, FCS measurements were made on a LSM 780 microscope equipped with a 40X 1.2 NA water immersion objective and an avalanche photodiode (Zeiss, Jena, Germany) at room temperature using 488 nm excitation. The focal volume was calibrated using Alexa 488 dye (Life [30, 31] . Statistical analysis on diffusion coefficients was done using Wilcoxon rank sum test. Autocorrelation analysis and data plotting were carried out using a MATLAB script developed in our lab. Our original model is based on the idea that SPD-5 molecules exist in two different forms [1] . We distinguish the form that is soluble in the cytoplasm and the form that tends to aggregate and phase separate from the cytoplasm. This form is thus the basis of the PCM phase that forms the centrosome. The two forms of SPD-5 can be converted into each other by chemical processes such as phosphorylation. We showed that the conversion of to must be autocatalytic to account for the sigmoidal centrosome growth curves and the reliable initiation of PCM accumulation at the centrioles [1] .
We extend our original model by distinguishing wild-type SPD-5 WT from mutant SPD-5 4A . Potentially, both species can exist in the and the form and we thus introduce four molecular species: WT , WT , 4A , and 4A . The dynamics of SPD-5 WT and SPD-5 4A in the cytoplasm, as revealed by fluorescent correlation spectroscopy (FCS) measurements, are very similar ( Figure S4 ). We thus consider both forms to have the same properties, such that they are both soluble in cytoplasm and can also diffuse in the PCM. The PCM can be formed by aggregation of either WT or 4A or by their combined aggregation (Figures 1B and C and 2C and 1D). We thus infer that they tend to phase separate together in one phase. The PCM volume is thus given by = ! / ! , where ! = ! WT + ! 4A is the total number of molecules in form and ! is the density of molecules in the PCM. Our data suggests that the density of SPD-5 in the PCM changes only slightly during centrosome growth (Figure 2A ). For simplicity, we here consider the case where the density ! is determined by the physics of phase separation and is constant over time. Below we discuss possible causes for the observed small density variations.
The PCM size increases if molecules of form are generated from their respective forms. Since PCM growth is reaction-limited [1] , the molecules can distribute in the PCM more quickly than they get converted to the form.
Consequently, the densities ! WT and ! 4A of the forms are approximately homogeneous throughout the PCM. We consider the simple case where the two forms do not interact with each other, such that we can discuss their densities separately. In the simplest case, the equilibrium of the form between the inside and the outside is given by an equilibrium constant ! , which implies that the density ! ! inside the PCM is proportional to the respective density ! ! of the form in the cytoplasm, ! ! = ! ! ! for = WT, 4A. Here, ! can be interpreted as an affinity of the PCM toward molecules of species ! .
Chemical reactions lead to the creation and removal of molecules of form inside the PCM, which is described by [1] 
for = WT, 4A. Here, the first two terms describe the production of a single molecule, while the last term accounts for the back-reaction → . The rateconstant ! in the first term quantifies the rate of the autocatalytic reaction + → 2 . The second term accounts for the catalytic activity of the centrioles, which is quantified by the reaction flux ! . Note that this catalytic activity is necessary to initiate centrosome growth [1] and to stabilize two centrosomes in the same cell [2] . We consider the case where both this catalytic and the autocatalytic reaction are driven by the same enzyme, e.g., PLK-1. We thus choose the ratio ! = ! / ! of the reaction rates to be the same for the wild-type and the mutant, respectively. Here, ! is proportional to the number of catalytic sites on the centrioles.
For the simple case where centrosomes start growing around bare centrioles without PCM, ! ! ( = 0) = 0, and the concentration ! ! in the cytoplasm remains constant, the number ! ! of moleculs in the PCM evolve as
Here,
is the PCM growth rate. If we include the depletion of the form in the cytoplasm, ! ! ( ) exhibits sigmoidal growth [1] . Since we do not observe a saturation of ! ! in our experimental data, we focus on the early growth phase where depletion can be neglected.
We compared the predictions of our model to our experimental measurements. In our experiments, we label one of the SPD-5 species with GFP, such that the measured total centrosome fluorescent intensity is a proxy for the total number ! = ! ! + ! ! of molecules of species , where ! ! = ! ! , and is the PCM volume. For the case !" ≪ , the time evolution of can be approximated by
Consequently, the total number of molecules is given by
We use this functional form to measure the growth rate by fitting the function = ( !" − 1) to our measured intensities multiplied by the centrosome volume as a function of time ( Figure 4F ). Here, the prefactor sets the intensity scale. The measured growth rates were WT = 0. Since the cytoplasmic concentrations ! ! of the fluorescent SPD-5's are similar ( Figure S1 ) we conclude that the binding coefficients
In fact, 4A might even be larger than WT . Consequently, a reduced binding efficiency of the mutant is not consistent with our data.
The only possible explanation for the mutant's reduced contribution to PCM growth is that the conversion rate of the mutant from form to form must be much smaller than that of the wild-type ( 4A ≪ WT ). Since the mutant cannot be phosphorylated by PLK-1, this furthermore suggests that phosphorylation by PLK-1 plays an important role in this conversion.
Our model implies that the PCM growth rate is proportional to the concentration of SPD-5 WT , since 4A ≪ WT . We tested this prediction with two additional experiments. First, we quantified centrosome growth in an experiment where both mutant and wild-type SPD-5 were expressed. Using Equation (3), we express the growth rate both in terms of the already measured growth rate
). In our experiment, 71% of the SPD-5 molecules are wild-type ( Figure S1 ), which implies both = 0.71
This value agrees well with the measured rate 0.31 ± 0.11 min !! . Second, we reduced the concentration of SPD-5 WT to a fraction of the wild-type concentration without introducing SPD-5 4A and found that the PCM volume is reduced by a similar fraction ( Figure 2H-J) . In summary, our model can capture the growth behavior in all our experiments when the only effect of the mutation of SPD-5 is that it cannot transition from form to form .
In addition to the growth behavior discussed above, we also observed a slight increase in the density of wild-type SPD-5 over time in the experiment without the mutant ( Figure 2A ). Our current model does not explain this behavior, since it considers phase separation with a constant density ! of SPD-5 in its form.
However, the PCM is not a simple incompressible fluid but a complex polymeric material. Therefore, the incorporation of SPD-5 can lead to a transient buildup of elastic stresses in the PCM, which then relax, e.g., by internal rearrangement of SPD-5 molecules. If this relaxation is slow compared to the SPD-5 incorporation rate , we expect increased SPD-5 densities over time. Conversely, if the relaxation rate is larger than or comparable to , the density would be rather constant. We indeed observe these two cases in our experiments (Figure 2A ).
Our data thus suggests that if only wild-type SPD-5 is present, PCM grows faster than stresses can relax, while they relax during the slower growth in the presence of SPD-5 4A . Note however that the presence of GFP::SPD-5 4A not only affects the growth rate , but might also have an effect on the relaxation rate, which we cannot measure directly. We therefore did not analyze this further.
Nevertheless, these arguments imply a slow stress relaxation rate of less than 
